ClinicalTrials.gg
Sign In

Leukemia, Lymphocytic, Chronic, B-Cell clinical trials

The registry lists 2,036 studies for Leukemia, Lymphocytic, Chronic, B-Cell across more than 10 countries. 237 are recruiting or about to start. 1,010 of them are mainly about Leukemia, Lymphocytic, Chronic, B-Cell (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

ClinicalTrials.gov finds 2,258 studies for Leukemia, Lymphocytic, Chronic, B-Cell. How that becomes 2,036 here

This page counts the studies the registry files under Leukemia, Lymphocytic, Chronic, B-Cell, and those it files under no condition that list Leukemia, Lymphocytic, Chronic, B-Cellthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,258Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −21List Leukemia, Lymphocytic, Chronic, B-Cell as a condition, but the registry did not file them under itMost often written as “CLL (Chronic Lymphocytic Leukemia)” (8), “Chronic Lymphocytic Lymphoma” (2), and “B-Chronic Lymphocytic Leukemia” (1). The registry filed them under other conditions only, most often Leukemia, B-Cell (14) and Precursor Cell Lymphoblastic Leukemia-Lymphoma (6).
  3. −212Match it another way25 name it in the title, 5 in a keyword, and 182 by a synonym or other text the search reads.
  4. 2,025Counted here and found by its search7 of them list Leukemia, Lymphocytic, Chronic, B-Cell in their own words; the registry filed them under no condition.
  5. +11
    Counted here, but its search does not find them
  6. 2,036The count on this page

Get an email when these change. Save the Leukemia, Lymphocytic, Chronic, B-Cell studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
1,105
Terminated
327
Recruiting
188
Active, not recruiting
148
Status unknown
112
Withdrawn
98

Phase

Phase 2
931
Phase 1
797
Phase 3
178
Phase 4
16
Early Phase 1
16

Where

United States
1,501
France
169
Italy
166
Germany
144
United Kingdom
138
Spain
130

Who runs them

National Cancer Institute (NCI) (134) · M.D. Anderson Cancer Center (118) · Fred Hutchinson Cancer Center (82) · Mayo Clinic (45) · City of Hope Medical Center (40) · Memorial Sloan Kettering Cancer Center (39) · Hoffmann-La Roche (36) · Gilead Sciences (35)

What is being tested here

Drugs under test in Leukemia, Lymphocytic, Chronic, B-Cell studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Venetoclax211567
Obinutuzumab161353
Pirtobrutinib13522
Acalabrutinib11838
Zanubrutinib9420
Ibrutinib81580
Sonrotoclax8411
ARQ531739
Tacabrutideg738
Fludarabine414166

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 56 open · Alkylating agents 6 open · Antimetabolites 6 open · Immune checkpoint inhibitors 2 open · mTOR inhibitors 1 open

Coming up

46phase 3 studies under way
109studies finish main data collection within a year6 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 188 Leukemia, Lymphocytic, Chronic, B-Cell studies recruiting now, 150 (80%) set no upper age limit and 15 (8%) stop at 75 or younger. 17 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 13 (7%) take healthy volunteers.

Recruiting studies that take each age, of 188
AgeWomenMen
1011 (6%)11 (6%)
18181 (96%)181 (96%)
30183 (97%)183 (97%)
40185 (98%)185 (98%)
50185 (98%)185 (98%)
65186 (99%)186 (99%)
75185 (98%)185 (98%)
85166 (88%)166 (88%)

Across all 2,036 studies, recruiting or not: 18% stop at 75 or younger and 7% at 65; 18% take children; <1% are for women only and <1% for men only; 3% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Leukemia, Lymphocytic, Chronic, B-Cell studies take

Of 249 phase 2 interventional studies under Leukemia, Lymphocytic, Chronic, B-Cell, half reached primary completion within 73 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 156 mo39–86 · 180 studies56 mo38–73 · 84 studies56 mo39–91 · 96 studies
Phase 1/278 mo51–103 · 90 studies80 mo51–104 · 50 studies76 mo53–103 · 40 studies
Phase 273 mo41–114 · 249 studies55 mo26–87 · 41 studies75 mo42–119 · 208 studies
Phase 359 mo43–76 · 83 studies53 mo41–73 · 57 studies—
Interventional, no phase50 mo31–134 · 39 studies—50 mo31–134 · 37 studies
Observational60 mo32–176 · 104 studies54 mo35–66 · 34 studies72 mo30–… · 70 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting3

Results posted2

Stopped2

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 2,036. Browse all 2,036 → or search them.